Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MITIGATE-NeoBOMB1: 68Ga-NeoBOMB1 PET/CT in Advanced GIST
NCT02931929Phase 2Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Nov 2016
- Primary completion
- Apr 2019
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of gallium Ga 68 DOTA-NeoBOMB1 in gastrointestinal stromal tumor (GIST), sponsored by Medical University of Innsbruck. Started Nov 2016; status: completed.
02
Drugs
gallium Ga 68 DOTA-NeoBOMB1
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT02931929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02931929.